Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 99 entries
Sorted by: Best Match Show Resources per page
Cutaneous CD8+ Cytotoxic T-Cell Lymphoma Infiltrates: Clinicopathological Correlation and Outcome of 35 Cases.

Oncology and therapy

Wobser M, Reinartz T, Roth S, Goebeler M, Rosenwald A, Geissinger E.
PMID: 28261650
Oncol Ther. 2016;4(2):199-210. doi: 10.1007/s40487-016-0026-y. Epub 2016 Aug 18.

INTRODUCTION: Cytotoxic CD8+ T-cell lymphomas are only rarely encountered and thus remain only poorly characterized. Our aim was to collect and correlate clinical and histological data of CD8+ skin lymphoma infiltrates to obtain a proper subtype assignment of CD8+...

Cite
Wobser M, Reinartz T, Roth S, et al. Cutaneous CD8+ Cytotoxic T-Cell Lymphoma Infiltrates: Clinicopathological Correlation and Outcome of 35 Cases. Oncol Ther. 2016;4(2):199-210doi: 10.1007/s40487-016-0026-y.
Wobser, M., Reinartz, T., Roth, S., Goebeler, M., Rosenwald, A., & Geissinger, E. (2016). Cutaneous CD8+ Cytotoxic T-Cell Lymphoma Infiltrates: Clinicopathological Correlation and Outcome of 35 Cases. Oncology and therapy, 4(2), 199-210. https://doi.org/10.1007/s40487-016-0026-y
Wobser, Marion, et al. "Cutaneous CD8+ Cytotoxic T-Cell Lymphoma Infiltrates: Clinicopathological Correlation and Outcome of 35 Cases." Oncology and therapy vol. 4,2 (2016): 199-210. doi: https://doi.org/10.1007/s40487-016-0026-y
Wobser M, Reinartz T, Roth S, Goebeler M, Rosenwald A, Geissinger E. Cutaneous CD8+ Cytotoxic T-Cell Lymphoma Infiltrates: Clinicopathological Correlation and Outcome of 35 Cases. Oncol Ther. 2016;4(2):199-210. doi: 10.1007/s40487-016-0026-y. Epub 2016 Aug 18. PMID: 28261650; PMCID: PMC5315091.
Copy Download .nbib Format: NLM
[In Process Citation].

Leukemia research

Gisslinger H, Penka M.
PMID: 27130523
Leuk Res. 2016 May;44:v. doi: 10.1016/S0145-2126(16)30070-4. Epub 2016 Apr 26.

No abstract available.

Cite
Gisslinger H, Penka M. [In Process Citation]. Leuk Res. 2016;44:vdoi: 10.1016/S0145-2126(16)30070-4.
Gisslinger, H., & Penka, M. (2016). [In Process Citation]. Leukemia research, 44v. https://doi.org/10.1016/S0145-2126(16)30070-4
Gisslinger, Heinz, and Penka, Miroslav. "[In Process Citation]." Leukemia research vol. 44 (2016): v. doi: https://doi.org/10.1016/S0145-2126(16)30070-4
Gisslinger H, Penka M. [In Process Citation]. Leuk Res. 2016 May;44:v. doi: 10.1016/S0145-2126(16)30070-4. Epub 2016 Apr 26. PMID: 27130523.
Copy Download .nbib Format: NLM
A readout scheme providing high spatial resolution for distributed fluorescent sensors on optical fibers.

Analytical chemistry

Prince BJ, Schwabacher AW, Geissinger P.
PMID: 11289410
Anal Chem. 2001 Mar 01;73(5):1007-15. doi: 10.1021/ac0011437.

Optical fiber sensors using fluorescent probes distributed along the fiber cladding are of great interest for monitoring physical and chemical properties in their environment. The location of an emitting fluorophore along a fiber can be determined by measuring the...

Cite
Prince BJ, Schwabacher AW, Geissinger P. A readout scheme providing high spatial resolution for distributed fluorescent sensors on optical fibers. Anal Chem. 2001;73(5):1007-15doi: 10.1021/ac0011437.
Prince, B. J., Schwabacher, A. W., & Geissinger, P. (2001). A readout scheme providing high spatial resolution for distributed fluorescent sensors on optical fibers. Analytical chemistry, 73(5), 1007-15. https://doi.org/10.1021/ac0011437
Prince, B J, et al. "A readout scheme providing high spatial resolution for distributed fluorescent sensors on optical fibers." Analytical chemistry vol. 73,5 (2001): 1007-15. doi: https://doi.org/10.1021/ac0011437
Prince BJ, Schwabacher AW, Geissinger P. A readout scheme providing high spatial resolution for distributed fluorescent sensors on optical fibers. Anal Chem. 2001 Mar 01;73(5):1007-15. doi: 10.1021/ac0011437. PMID: 11289410.
Copy Download .nbib Format: NLM
Analysis of single nucleotide polymorphisms in the FAS and CTLA-4 genes of peripheral T-cell lymphomas.

Journal of hematopathology

Bonzheim I, Geissinger E, Chuang WY, Roth S, Ströbel P, Marx A, Reimer P, Wilhelm M, Puppe B, Rosenwald A, Müller-Hermelink HK, Rüdiger T.
PMID: 19669200
J Hematop. 2008 Jul;1(1):11-21. doi: 10.1007/s12308-008-0003-y. Epub 2008 Apr 24.

Angioimmunoblastic T-cell lymphoma (AILT) represents a subset of T-cell lymphomas but resembles an autoimmune disease in many of its clinical aspects. Despite the phenotype of effector T-cells and high expression of FAS and CTLA-4 receptor molecules, tumor cells fail...

Cite
Bonzheim I, Geissinger E, Chuang WY, et al. Analysis of single nucleotide polymorphisms in the FAS and CTLA-4 genes of peripheral T-cell lymphomas. J Hematop. 2008;1(1):11-21doi: 10.1007/s12308-008-0003-y.
Bonzheim, I., Geissinger, E., Chuang, W. Y., Roth, S., Ströbel, P., Marx, A., Reimer, P., Wilhelm, M., Puppe, B., Rosenwald, A., Müller-Hermelink, H. K., & Rüdiger, T. (2008). Analysis of single nucleotide polymorphisms in the FAS and CTLA-4 genes of peripheral T-cell lymphomas. Journal of hematopathology, 1(1), 11-21. https://doi.org/10.1007/s12308-008-0003-y
Bonzheim, Irina, et al. "Analysis of single nucleotide polymorphisms in the FAS and CTLA-4 genes of peripheral T-cell lymphomas." Journal of hematopathology vol. 1,1 (2008): 11-21. doi: https://doi.org/10.1007/s12308-008-0003-y
Bonzheim I, Geissinger E, Chuang WY, Roth S, Ströbel P, Marx A, Reimer P, Wilhelm M, Puppe B, Rosenwald A, Müller-Hermelink HK, Rüdiger T. Analysis of single nucleotide polymorphisms in the FAS and CTLA-4 genes of peripheral T-cell lymphomas. J Hematop. 2008 Jul;1(1):11-21. doi: 10.1007/s12308-008-0003-y. Epub 2008 Apr 24. PMID: 19669200; PMCID: PMC2712330.
Copy Download .nbib Format: NLM
Vibrational Predissociation Spectroscopy of Cold Protonated Tryptophan with Different Messenger Tags.

The journal of physical chemistry. A

Spieler S, Duong CH, Kaiser A, Duensing F, Geistlinger K, Fischer M, Yang N, Kumar SS, Johnson MA, Wester R.
PMID: 30208709
J Phys Chem A. 2018 Oct 11;122(40):8037-8046. doi: 10.1021/acs.jpca.8b07532. Epub 2018 Oct 01.

Vibrational spectra of protonated tryptophan were recorded by predissociation of H

Cite
Spieler S, Duong CH, Kaiser A, et al. Vibrational Predissociation Spectroscopy of Cold Protonated Tryptophan with Different Messenger Tags. J Phys Chem A. 2018;122(40):8037-8046doi: 10.1021/acs.jpca.8b07532.
Spieler, S., Duong, C. H., Kaiser, A., Duensing, F., Geistlinger, K., Fischer, M., Yang, N., Kumar, S. S., Johnson, M. A., & Wester, R. (2018). Vibrational Predissociation Spectroscopy of Cold Protonated Tryptophan with Different Messenger Tags. The journal of physical chemistry. A, 122(40), 8037-8046. https://doi.org/10.1021/acs.jpca.8b07532
Spieler, Steffen, et al. "Vibrational Predissociation Spectroscopy of Cold Protonated Tryptophan with Different Messenger Tags." The journal of physical chemistry. A vol. 122,40 (2018): 8037-8046. doi: https://doi.org/10.1021/acs.jpca.8b07532
Spieler S, Duong CH, Kaiser A, Duensing F, Geistlinger K, Fischer M, Yang N, Kumar SS, Johnson MA, Wester R. Vibrational Predissociation Spectroscopy of Cold Protonated Tryptophan with Different Messenger Tags. J Phys Chem A. 2018 Oct 11;122(40):8037-8046. doi: 10.1021/acs.jpca.8b07532. Epub 2018 Oct 01. PMID: 30208709.
Copy Download .nbib Format: NLM
Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis.

Leukemia

Harrison CN, Vannucchi AM, Kiladjian JJ, Al-Ali HK, Gisslinger H, Knoops L, Cervantes F, Jones MM, Sun K, McQuitty M, Stalbovskaya V, Gopalakrishna P, Barbui T.
PMID: 28248313
Leukemia. 2017 Mar;31(3):775. doi: 10.1038/leu.2016.323.

No abstract available.

Cite
Harrison CN, Vannucchi AM, Kiladjian JJ, et al. Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis. Leukemia. 2017;31(3):775doi: 10.1038/leu.2016.323.
Harrison, C. N., Vannucchi, A. M., Kiladjian, J. J., Al-Ali, H. K., Gisslinger, H., Knoops, L., Cervantes, F., Jones, M. M., Sun, K., McQuitty, M., Stalbovskaya, V., Gopalakrishna, P., & Barbui, T. (2017). Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis. Leukemia, 31(3), 775. https://doi.org/10.1038/leu.2016.323
Harrison, C N, et al. "Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis." Leukemia vol. 31,3 (2017): 775. doi: https://doi.org/10.1038/leu.2016.323
Harrison CN, Vannucchi AM, Kiladjian JJ, Al-Ali HK, Gisslinger H, Knoops L, Cervantes F, Jones MM, Sun K, McQuitty M, Stalbovskaya V, Gopalakrishna P, Barbui T. Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis. Leukemia. 2017 Mar;31(3):775. doi: 10.1038/leu.2016.323. PMID: 28248313; PMCID: PMC7609269.
Copy Download .nbib Format: NLM
Impact of white blood cells on thrombotic risk in patients with optimized platelet count in essential thrombocythemia.

European journal of haematology

Buxhofer-Ausch V, Steurer M, Sormann S, Schloegl E, Schimetta W, Gisslinger B, Schalling M, Krauth MT, Thiele J, Ruckser R, Gastl G, Gisslinger H.
PMID: 29603799
Eur J Haematol. 2018 Mar 30; doi: 10.1111/ejh.13070. Epub 2018 Mar 30.

OBJECTIVES: Risk of thrombosis is significantly enhanced by both elevated platelet (PLT) and white blood cell (WBC) counts according to a retrospective analysis of a large anagrelide registry in thrombocythemic MPN patients. We were interested in the impact of...

Cite
Buxhofer-Ausch V, Steurer M, Sormann S, et al. Impact of white blood cells on thrombotic risk in patients with optimized platelet count in essential thrombocythemia. Eur J Haematol. 2018;doi: 10.1111/ejh.13070.
Buxhofer-Ausch, V., Steurer, M., Sormann, S., Schloegl, E., Schimetta, W., Gisslinger, B., Schalling, M., Krauth, M. T., Thiele, J., Ruckser, R., Gastl, G., & Gisslinger, H. (2018). Impact of white blood cells on thrombotic risk in patients with optimized platelet count in essential thrombocythemia. European journal of haematology, . https://doi.org/10.1111/ejh.13070
Buxhofer-Ausch, Veronika, et al. "Impact of white blood cells on thrombotic risk in patients with optimized platelet count in essential thrombocythemia." European journal of haematology vol. (2018). doi: https://doi.org/10.1111/ejh.13070
Buxhofer-Ausch V, Steurer M, Sormann S, Schloegl E, Schimetta W, Gisslinger B, Schalling M, Krauth MT, Thiele J, Ruckser R, Gastl G, Gisslinger H. Impact of white blood cells on thrombotic risk in patients with optimized platelet count in essential thrombocythemia. Eur J Haematol. 2018 Mar 30; doi: 10.1111/ejh.13070. Epub 2018 Mar 30. PMID: 29603799.
Copy Download .nbib Format: NLM
Clinical, Hematologic, Biologic and Molecular Characteristics of Patients with Myeloproliferative Neoplasms and a Chronic Myelomonocytic Leukemia-Like Phenotype.

Cancers

Heibl S, Gisslinger B, Jäger E, Barna A, Gurbisz M, Stegemann M, Bettelheim P, Machherndl-Spandl S, Pfeilstöcker M, Nösslinger T, Uyanik G, Hoermann G, Stauder R, Thaler J, Kusec R, Valent P, Gisslinger H, Geissler K.
PMID: 32674283
Cancers (Basel). 2020 Jul 14;12(7). doi: 10.3390/cancers12071891.

Patients with a myeloproliferative neoplasm (MPN) sometimes show a chronic myelomonocytic leukemia (CMML)-like phenotype but, according to the 2016 WHO classification, a documented history of an MPN excludes the diagnosis of CMML. Forty-one patients with an MPN (35 polycythemia...

Cite
Heibl S, Gisslinger B, Jäger E, et al. Clinical, Hematologic, Biologic and Molecular Characteristics of Patients with Myeloproliferative Neoplasms and a Chronic Myelomonocytic Leukemia-Like Phenotype. Cancers (Basel). 2020;12(7)doi: 10.3390/cancers12071891.
Heibl, S., Gisslinger, B., Jäger, E., Barna, A., Gurbisz, M., Stegemann, M., Bettelheim, P., Machherndl-Spandl, S., Pfeilstöcker, M., Nösslinger, T., Uyanik, G., Hoermann, G., Stauder, R., Thaler, J., Kusec, R., Valent, P., Gisslinger, H., & Geissler, K. (2020). Clinical, Hematologic, Biologic and Molecular Characteristics of Patients with Myeloproliferative Neoplasms and a Chronic Myelomonocytic Leukemia-Like Phenotype. Cancers, 12(7), . https://doi.org/10.3390/cancers12071891
Heibl, Sonja, et al. "Clinical, Hematologic, Biologic and Molecular Characteristics of Patients with Myeloproliferative Neoplasms and a Chronic Myelomonocytic Leukemia-Like Phenotype." Cancers vol. 12,7 (2020). doi: https://doi.org/10.3390/cancers12071891
Heibl S, Gisslinger B, Jäger E, Barna A, Gurbisz M, Stegemann M, Bettelheim P, Machherndl-Spandl S, Pfeilstöcker M, Nösslinger T, Uyanik G, Hoermann G, Stauder R, Thaler J, Kusec R, Valent P, Gisslinger H, Geissler K. Clinical, Hematologic, Biologic and Molecular Characteristics of Patients with Myeloproliferative Neoplasms and a Chronic Myelomonocytic Leukemia-Like Phenotype. Cancers (Basel). 2020 Jul 14;12(7). doi: 10.3390/cancers12071891. PMID: 32674283; PMCID: PMC7409251.
Copy Download .nbib Format: NLM
Characterization of ACE Inhibitors and AT.

Life (Basel, Switzerland)

Reus P, Schneider AK, Ulshöfer T, Henke M, Bojkova D, Cinatl J, Ciesek S, Geisslinger G, Laux V, Grättinger M, Gribbon P, Schiffmann S.
PMID: 34440554
Life (Basel). 2021 Aug 10;11(8). doi: 10.3390/life11080810.

Blood-pressure-lowering drugs are proposed to foster SARS-CoV-2 infection by pharmacological upregulation of angiotensin-converting enzyme 2 (ACE2), the binding partner of the virus spike (S) protein, located on the surface of the host cells. Conversely, it is postulated that angiotensin-renin...

Cite
Reus P, Schneider AK, Ulshöfer T, et al. Characterization of ACE Inhibitors and AT. Life (Basel). 2021;11(8)doi: 10.3390/life11080810.
Reus, P., Schneider, A. K., Ulshöfer, T., Henke, M., Bojkova, D., Cinatl, J., Ciesek, S., Geisslinger, G., Laux, V., Grättinger, M., Gribbon, P., & Schiffmann, S. (2021). Characterization of ACE Inhibitors and AT. Life (Basel, Switzerland), 11(8), . https://doi.org/10.3390/life11080810
Reus, Philipp, et al. "Characterization of ACE Inhibitors and AT." Life (Basel, Switzerland) vol. 11,8 (2021). doi: https://doi.org/10.3390/life11080810
Reus P, Schneider AK, Ulshöfer T, Henke M, Bojkova D, Cinatl J, Ciesek S, Geisslinger G, Laux V, Grättinger M, Gribbon P, Schiffmann S. Characterization of ACE Inhibitors and AT. Life (Basel). 2021 Aug 10;11(8). doi: 10.3390/life11080810. PMID: 34440554; PMCID: PMC8399150.
Copy Download .nbib Format: NLM
Multiomic Integration of Public Oncology Databases in Bioconductor.

JCO clinical cancer informatics

Ramos M, Geistlinger L, Oh S, Schiffer L, Azhar R, Kodali H, de Bruijn I, Gao J, Carey VJ, Morgan M, Waldron L.
PMID: 33119407
JCO Clin Cancer Inform. 2020 Oct;4:958-971. doi: 10.1200/CCI.19.00119.

PURPOSE: Investigations of the molecular basis for the development, progression, and treatment of cancer increasingly use complementary genomic assays to gather multiomic data, but management and analysis of such data remain complex. The cBioPortal for cancer genomics currently provides...

Cite
Ramos M, Geistlinger L, Oh S, et al. Multiomic Integration of Public Oncology Databases in Bioconductor. JCO Clin Cancer Inform. 2020;4:958-971doi: 10.1200/CCI.19.00119.
Ramos, M., Geistlinger, L., Oh, S., Schiffer, L., Azhar, R., Kodali, H., de Bruijn, I., Gao, J., Carey, V. J., Morgan, M., & Waldron, L. (2020). Multiomic Integration of Public Oncology Databases in Bioconductor. JCO clinical cancer informatics, 4958-971. https://doi.org/10.1200/CCI.19.00119
Ramos, Marcel, et al. "Multiomic Integration of Public Oncology Databases in Bioconductor." JCO clinical cancer informatics vol. 4 (2020): 958-971. doi: https://doi.org/10.1200/CCI.19.00119
Ramos M, Geistlinger L, Oh S, Schiffer L, Azhar R, Kodali H, de Bruijn I, Gao J, Carey VJ, Morgan M, Waldron L. Multiomic Integration of Public Oncology Databases in Bioconductor. JCO Clin Cancer Inform. 2020 Oct;4:958-971. doi: 10.1200/CCI.19.00119. PMID: 33119407; PMCID: PMC7608653.
Copy Download .nbib Format: NLM
Oncogenic Mutations and Gene Fusions in CD30-Positive Lymphoproliferations and Clonally Related Mycosis Fungoides Occurring in the Same Patients.

JID innovations

Wobser M, Roth S, Appenzeller S, Kneitz H, Goebeler M, Geissinger E, Rosenwald A, Maurus K.
PMID: 34909731
JID Innov. 2021 Jun 15;1(3):100034. doi: 10.1016/j.xjidi.2021.100034. eCollection 2021 Sep.

The emergence of a common progenitor cell has been postulated for the association of CD30-positive lymphoproliferative disease (LPD) and mycosis fungoides (MF) within the same patient. Up to now, no comprehensive analysis has yet addressed the genetic profiles of...

Cite
Wobser M, Roth S, Appenzeller S, et al. Oncogenic Mutations and Gene Fusions in CD30-Positive Lymphoproliferations and Clonally Related Mycosis Fungoides Occurring in the Same Patients. JID Innov. 2021;1(3):100034doi: 10.1016/j.xjidi.2021.100034.
Wobser, M., Roth, S., Appenzeller, S., Kneitz, H., Goebeler, M., Geissinger, E., Rosenwald, A., & Maurus, K. (2021). Oncogenic Mutations and Gene Fusions in CD30-Positive Lymphoproliferations and Clonally Related Mycosis Fungoides Occurring in the Same Patients. JID innovations, 1(3), 100034. https://doi.org/10.1016/j.xjidi.2021.100034
Wobser, Marion, et al. "Oncogenic Mutations and Gene Fusions in CD30-Positive Lymphoproliferations and Clonally Related Mycosis Fungoides Occurring in the Same Patients." JID innovations vol. 1,3 (2021): 100034. doi: https://doi.org/10.1016/j.xjidi.2021.100034
Wobser M, Roth S, Appenzeller S, Kneitz H, Goebeler M, Geissinger E, Rosenwald A, Maurus K. Oncogenic Mutations and Gene Fusions in CD30-Positive Lymphoproliferations and Clonally Related Mycosis Fungoides Occurring in the Same Patients. JID Innov. 2021 Jun 15;1(3):100034. doi: 10.1016/j.xjidi.2021.100034. eCollection 2021 Sep. PMID: 34909731; PMCID: PMC8659398.
Copy Download .nbib Format: NLM
Infographic. Clinical recommendations for return to play during the COVID-19 pandemic.

British journal of sports medicine

Löllgen H, Bachl N, Papadopoulou T, Shafik A, Holloway G, Vonbank K, Jones NE, Bigard X, Niederseer D, Meyer J, Muniz-Pardos B, Debruyne A, Zupet P, Steinacker JM, Wolfarth B, Bilzon JLJ, Ionescu A, Dohi M, Swart J, Badtieva V, Zelenkova I, Casasco M, Geistlinger M, Di Luigi L, Webborn N, Singleton P, Miller M, Pigozzi F, Pitsiladis YP.
PMID: 32883690
Br J Sports Med. 2021 Mar;55(6):344-345. doi: 10.1136/bjsports-2020-102985. Epub 2020 Sep 03.

No abstract available.

Cite
Löllgen H, Bachl N, Papadopoulou T, et al. Infographic. Clinical recommendations for return to play during the COVID-19 pandemic. Br J Sports Med. 2020;55(6):344-345doi: 10.1136/bjsports-2020-102985.
Löllgen, H., Bachl, N., Papadopoulou, T., Shafik, A., Holloway, G., Vonbank, K., Jones, N. E., Bigard, X., Niederseer, D., Meyer, J., Muniz-Pardos, B., Debruyne, A., Zupet, P., Steinacker, J. M., Wolfarth, B., Bilzon, J. L. J., Ionescu, A., Dohi, M., Swart, J., Badtieva, V., Zelenkova, I., Casasco, M., Geistlinger, M., Di Luigi, L., Webborn, N., Singleton, P., Miller, M., Pigozzi, F., & Pitsiladis, Y. P. (2021). Infographic. Clinical recommendations for return to play during the COVID-19 pandemic. British journal of sports medicine, 55(6), 344-345. https://doi.org/10.1136/bjsports-2020-102985
Löllgen, Herbert, et al. "Infographic. Clinical recommendations for return to play during the COVID-19 pandemic." British journal of sports medicine vol. 55,6 (2021): 344-345. doi: https://doi.org/10.1136/bjsports-2020-102985
Löllgen H, Bachl N, Papadopoulou T, Shafik A, Holloway G, Vonbank K, Jones NE, Bigard X, Niederseer D, Meyer J, Muniz-Pardos B, Debruyne A, Zupet P, Steinacker JM, Wolfarth B, Bilzon JLJ, Ionescu A, Dohi M, Swart J, Badtieva V, Zelenkova I, Casasco M, Geistlinger M, Di Luigi L, Webborn N, Singleton P, Miller M, Pigozzi F, Pitsiladis YP. Infographic. Clinical recommendations for return to play during the COVID-19 pandemic. Br J Sports Med. 2021 Mar;55(6):344-345. doi: 10.1136/bjsports-2020-102985. Epub 2020 Sep 03. PMID: 32883690; PMCID: PMC7476424.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 99 entries